US Stock MarketDetailed Quotes
SYRS Syros Pharmaceuticals
- 0.2000
- -0.0018-0.89%
Close Dec 20 16:00 ET
- 0.2069
- +0.0069+3.45%
Post 20:01 ET
5.37MMarket Cap-0.07P/E (TTM)
0.2200High0.2000Low2.84MVolume0.2100Open0.2018Pre Close603.61KTurnover21.62%Turnover RatioLossP/E (Static)26.83MShares8.170052wk High-0.48P/B2.63MFloat Cap0.183052wk Low--Dividend TTM13.14MShs Float243.7500Historical High--Div YieldTTM9.91%Amplitude0.1830Historical Low0.2120Avg Price1Lot Size
Syros Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -33.23%9.94M | 151.19%386K | -3.32%3.76M | -54.86%2.83M | -45.97%2.95M | -36.65%14.88M | -109.66%-754K |
| Operating revenue | --0 | --0 | --0 | -33.23%9.94M | 151.19%386K | -3.32%3.76M | -54.86%2.83M | -45.97%2.95M | -36.65%14.88M | -109.66%-754K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.36%26.18M | -25.57%27.42M | -14.50%30.92M | -3.40%136.44M | -22.28%27.39M | 6.53%36.04M | -8.02%36.83M | 12.60%36.17M | 14.92%141.24M | 6.07%35.24M |
| Selling and administrative expenses | -27.16%5.66M | -24.39%5.46M | -15.38%6.27M | -3.47%28.28M | -19.66%5.89M | -3.86%7.76M | 4.03%7.23M | 6.56%7.41M | 27.19%29.3M | 13.98%7.33M |
| -General and administrative expense | -27.16%5.66M | -24.39%5.46M | -15.38%6.27M | -3.47%28.28M | -19.66%5.89M | -3.86%7.76M | 4.03%7.23M | 6.56%7.41M | 27.19%29.3M | 13.98%7.33M |
| Research and development costs | -27.42%20.53M | -25.85%21.95M | -14.28%24.66M | -3.39%108.15M | -22.97%21.5M | 9.79%28.28M | -10.55%29.61M | 14.26%28.76M | 12.09%111.94M | 4.18%27.91M |
| Operating profit | 18.90%-26.18M | 19.36%-27.42M | 6.90%-30.92M | -0.11%-126.5M | 24.98%-27.01M | -7.81%-32.28M | -0.68%-34M | -24.61%-33.21M | -27.10%-126.36M | -41.59%-36M |
| Net non-operating interest income expense | -257.27%-519K | -135.06%-297K | -57.17%239K | 184.37%1.69M | -109.85%-46K | 150.08%330K | 197.47%847K | 159.30%558K | 47.59%-2M | 148.90%467K |
| Non-operating interest income | -51.44%793K | -48.94%1.09M | -12.90%1.55M | 219.70%6.82M | -19.46%1.28M | 316.58%1.63M | 1,797.32%2.13M | 4,971.43%1.78M | 2,350.57%2.13M | 5,038.71%1.59M |
| Non-operating interest expense | 0.69%1.31M | 8.14%1.38M | 7.40%1.31M | 24.02%5.13M | 18.03%1.33M | 23.98%1.3M | 30.28%1.28M | 24.69%1.22M | 5.81%4.13M | 14.20%1.13M |
| Other net income (expense) | 347.89%20.31M | 241.26%4.39M | 204.28%26.97M | -217.96%-39.76M | -221.38%-37.33M | -2,440.29%-8.19M | -2,077.71%-3.11M | 262.13%8.87M | 102.08%33.71M | 1,099.06%30.76M |
| Gain on sale of security | 447.87%20.31M | 241.26%4.39M | 204.28%26.97M | -186.24%-37.28M | -220.95%-37.2M | -159.20%-5.84M | -2,077.71%-3.11M | 262.13%8.87M | 159.09%43.22M | 1,099.06%30.76M |
| Special income (charges) | --0 | ---- | ---- | 73.83%-2.49M | ---135K | 75.25%-2.35M | ---- | ---- | ---9.51M | --0 |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | -73.83%2.49M | --135K | -75.25%2.35M | ---- | ---- | --9.51M | --0 |
| Income before tax | 84.07%-6.4M | 35.66%-23.33M | 84.41%-3.71M | -73.87%-164.57M | -1,248.64%-64.38M | -32.69%-40.14M | -5.15%-36.26M | 5.40%-23.79M | -9.35%-94.65M | 79.95%-4.77M |
| Income tax | ||||||||||
| Net income | 84.07%-6.4M | 35.66%-23.33M | 84.41%-3.71M | -73.87%-164.57M | -1,248.64%-64.38M | -32.69%-40.14M | -5.15%-36.26M | 5.40%-23.79M | -9.35%-94.65M | 79.95%-4.77M |
| Net income continuous Operations | 84.07%-6.4M | 35.66%-23.33M | 84.41%-3.71M | -73.87%-164.57M | -1,248.64%-64.38M | -32.69%-40.14M | -5.15%-36.26M | 5.40%-23.79M | -9.35%-94.65M | 79.95%-4.77M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 84.07%-6.4M | 35.66%-23.33M | 84.41%-3.71M | -73.87%-164.57M | -1,248.64%-64.38M | -32.69%-40.14M | -5.15%-36.26M | 5.40%-23.79M | -9.35%-94.65M | 79.95%-4.77M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 84.07%-6.4M | 35.66%-23.33M | 84.41%-3.71M | -73.87%-164.57M | -1,248.64%-64.38M | -32.69%-40.14M | -5.15%-36.26M | 5.40%-23.79M | -9.35%-94.65M | 79.95%-4.77M |
| Basic earnings per share | 88.81%-0.16 | 54.62%-0.59 | 88.24%-0.1 | 22.43%-5.81 | -842.28%-2.22 | 55.45%-1.43 | 75.93%-1.3 | 78.70%-0.85 | 45.88%-7.49 | 93.77%-0.2356 |
| Diluted earnings per share | 88.81%-0.16 | 54.62%-0.59 | 88.24%-0.1 | 22.43%-5.81 | -842.28%-2.22 | 55.45%-1.43 | 75.93%-1.3 | 78.70%-0.85 | 45.88%-7.49 | 93.77%-0.2356 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data